Monitoring bcr-abl by polymerase chain reaction in the treatment of chronic myeloid leukemia (Q35190705)

7 August 2017

1 reference

title

Monitoring bcr-abl by polymerase chain reaction in the treatment of chronic myeloid leukemia (English)

1 reference

7 August 2017

main subject

chronic myeloid leukemia

0 references

author name string

Vivian G Oehler

series ordinal

1

1 reference

7 August 2017

Jerald P Radich

series ordinal

2

1 reference

7 August 2017

publication date

1 September 2003

1 reference

7 August 2017

published in

Current Oncology Reports

1 reference

7 August 2017

volume

5

1 reference

7 August 2017

issue

5

1 reference

7 August 2017

page(s)

426-435

1 reference

describes a project that uses

7 August 2017

polymerase chain reaction

1 reference

Estimation of the number of mutations necessary to cause chronic myeloid leukaemia from epidemiological data

inferred from title

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-003-0030-X

Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse

21 January 2018

1 reference

12 December 2020

BCR-ABL, ABL-BCR, BCR, and ABL genes are all expressed in individual granulocyte-macrophage colony-forming unit colonies derived from blood of patients with chronic myeloid leukemia

1 reference

12 December 2020

Late relapsing childhood lymphoblastic leukemia

1 reference

12 December 2020

Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia

1 reference

12 December 2020

Exclusion of chromosomal mosaicism: tables of 90%, 95% and 99% confidence limits and comments on use

1 reference

12 December 2020

Detection of residual leukaemia more than 10 years after allogeneic bone marrow transplantation for chronic myelogenous leukaemia

1 reference

12 December 2020

Analysis of molecular breakpoint and m-RNA transcripts in a prospective randomized trial of interferon in chronic myeloid leukaemia: no correlation with clinical features, cytogenetic response, duration of chronic phase, or survival

1 reference

12 December 2020

Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results.

1 reference

12 December 2020

Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate.

1 reference

12 December 2020

Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia

1 reference

12 December 2020

Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics

1 reference

12 December 2020

Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority

1 reference

12 December 2020

A special fluorescent in situ hybridization technique to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia

1 reference

12 December 2020

Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha

1 reference

12 December 2020

The molecular biology of chronic myeloid leukemia.

1 reference

12 December 2020

Real time quantitative PCR

1 reference

12 December 2020

A comparison of the sensitivity of blood and bone marrow for the detection of minimal residual disease in chronic myeloid leukaemia

1 reference

12 December 2020

The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease.

1 reference

12 December 2020

Efficiency of interphase fluorescence in situ hybridization for BCR/ABL on peripheral blood smears for monitoring of CML patients: a comparison with bone marrow findings

1 reference

12 December 2020

The molecular biology of chronic myeloid leukaemia.

1 reference

12 December 2020

Fluorescence in situ hybridization on peripheral-blood specimens is a reliable method to evaluate cytogenetic response in chronic myeloid leukemia

1 reference

12 December 2020

The significance of bcr-abl molecular detection in chronic myeloid leukemia patients "late," 18 months or more after transplantation

1 reference

12 December 2020

Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia

1 reference

12 December 2020

Quantitative monitoring of BCR/ABL transcript during STI-571 therapy

1 reference

12 December 2020

Fluorescence in situ hybridization in combination with morphology detects minimal residual disease in remission and heralds relapse in acute leukaemia

1 reference

12 December 2020

Complete cytogenetic and molecular responses to interferon-alpha-based therapy for chronic myelogenous leukemia are associated with excellent long-term prognosis

1 reference

12 December 2020

Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients

1 reference

12 December 2020

Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia: a metaphase-FISH study

1 reference

12 December 2020

Absence of host-derived cells in the blood of patients in remission after allografting for chronic myeloid leukemia

1 reference

12 December 2020

Long persistent bcr-abl positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: a study of 64 patients

1 reference

12 December 2020

Variable numbers of BCR-ABL transcripts persist in CML patients who achieve complete cytogenetic remission with interferon-α

1 reference

12 December 2020

Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia

1 reference

12 December 2020

bcr-abl mRNA lacking abl exon a2 detected by polymerase chain reaction in a chronic myelogeneous leukemia patient.

1 reference

12 December 2020

The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene

1 reference

12 December 2020

Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR

1 reference

12 December 2020

The detection and significance of minimal residual disease in chronic myeloid leukemia.

1 reference

12 December 2020

Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction

1 reference

12 December 2020

Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse

1 reference

12 December 2020

Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia

1 reference

12 December 2020

Hypermetaphase fluorescence in situ hybridization for quantitative monitoring of Philadelphia chromosome-positive cells in patients with chronic myelogenous leukemia during treatment

1 reference

12 December 2020

Minimal residual disease in chronic myeloid leukaemia

1 reference

12 December 2020

Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia

1 reference

12 December 2020

Fluorescence in situ hybridization (FISH) on peripheral blood smears for monitoring Philadelphia chromosome-positive chronic myeloid leukemia (CML) during interferon treatment: A new strategy for remission assessment

1 reference

12 December 2020

Targeting multiple genetic aberrations in isolated tumor cells by spectral fluorescence in situ hybridization

1 reference

12 December 2020

T-cell cytogenetics in chronic granulocytic leukaemia

1 reference

12 December 2020

Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study

1 reference

12 December 2020

The biology of chronic myeloid leukemia

1 reference

12 December 2020

Cytogenetic events after bone marrow transplantation for chronic myeloid leukemia in chronic phase

1 reference

12 December 2020

No evidence for persistence of BCR-ABL-positive cells in patients in molecular remission after conventional allogenic transplantation for chronic myeloid leukemia

1 reference

12 December 2020

Comparison of genomic DNA and cDNA for detection of residual disease after treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation

1 reference

12 December 2020

Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using an in situ RT-PCR assay

1 reference

12 December 2020

Characterization of genomic BCR-ABL breakpoints in chronic myeloid leukaemia by PCR.

1 reference

12 December 2020

Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation

1 reference

12 December 2020

Quantitation of minimal residual disease in acute myelogenous leukemia and myelodysplastic syndromes in complete remission by molecular cytogenetics of progenitor cells

1 reference

12 December 2020

Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia

1 reference

12 December 2020

A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia

1 reference

12 December 2020

Incidence of involvement of the B and T lymphocyte lineages in chronic myelogenous leukemia.

1 reference

12 December 2020

Metaphase fluorescence in situ hybridization (FISH) in the follow-up of 60 patients with haemopoietic malignancies

1 reference

12 December 2020

Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real‐time quantitative RT‐PCR

1 reference

12 December 2020

Conversion of interferon-induced, long-term cytogenetic remissions in chronic myelogenous leukemia to polymerase chain reaction negativity

1 reference

12 December 2020

Persistence of RARa‐PML fusion mRNA detected by reverse transcriptase polymerase chain reaction in patients in long‐term remission of acute promyelocytic leukaemia

1 reference

12 December 2020

Chronic myelogenous leukemia

1 reference

12 December 2020

Avoiding false positives with PCR

1 reference

12 December 2020

Fluorescent in situ hybridization on flow-sorted cells as a tool for evaluating minimal residual disease or chimerism after allogenic bone marrow transplantation

1 reference

12 December 2020

Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia

1 reference

12 December 2020

Regulation of cell death by the Abl tyrosine kinase

1 reference

12 December 2020

Some observations on fluorescence in situ hybridization evaluation of chronic myelocytic leukemia

1 reference

12 December 2020

Monitoring the efficiency of interferon-alpha therapy in chronic myelogenous leukemia (CML) patients by competitive polymerase chain reaction

1 reference

12 December 2020

Persistence of BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after interferon-alpha therapy or allogeneic bone marrow transplantation

1 reference

12 December 2020

Bone Marrow Transplants from Unrelated Donors for Patients with Chronic Myeloid Leukemia

1 reference

12 December 2020

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

1 reference

12 December 2020

Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction

1 reference

12 December 2020

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.

1 reference

12 December 2020

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

12 December 2020

Value of PCR analysis for long term survivors after allogeneic bone marrow transplant for chronic myelogenous leukemia: a comparative study

1 reference

12 December 2020

10.1007/S11912-003-0030-X

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gstu2xl52rbtxduukqr6dobbay

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_gstu2xl52rbtxduukqr6dobbay

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gstu2xl52rbtxduukqr6dobbay

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/gstu2xl52rbtxduukqr6dobbay

1 reference

30 July 2022